Search Result
ATRC | Atricure Inc AtriCure, Inc.
You can also get more ATRC info from:
MarketWatch
CNBC
SeekingAlpha
Y!Finance
BarChart
Zacks
TheStreet
QuoteMedia
FinViz
Benzinga
StockTwits
Ycharts
GuruFocus
StockAnalysis
MarketBeat
美股之家
StreetInsider
雪球
Tiingo
Stocks Trading Charts
WSJ
TradingView
Martkets Insider
Robinhood
OTC Markets
Chartmill
Barrons
MarketChameleon
Stocklight
StockMarketWatch
Stockhouse
TD Ameritrade
TalkMarkets
Stocknews
Tipranks
InvestorsObserver
RealMoney
StockConsultant
Stockinvest
Investorplace
Swingtradebot
WalletInvestor
DividendInvestor
Dogsofthedow
Echofin
TradingEconomics
Polygon
Equities
Fidelity
StockInvestor
Fintel
EarningsWhispers
StockMonitor
InvestingPort
Whotrades
CapitalMarketLaboratories
FinancialContent
TMX Money
Stocks2
Trade-ideas
InsiderTracking
Kiplinger
CNN
SEC Fillings
WhaleWisdom
iBorrowDesk
雪球
Webb-Site
MG21
MG21
Y!Finance Chart
WhaleWisdom
MacroAxis
OutstandingSharesRecord
HoldingsChannel
StratoSphere
MyTrack
Result:1
Result:1
ATRC | Atricure Inc
Manufacturing | Surgical and Medical Instrument Manufacturing
Market Value: $1.82 Billion
Shares: 46,424,652
52-Week Range: 33-89
Market Value: $1.82 Billion
Shares: 46,424,652
52-Week Range: 33-89
IPO: 2005-08-05
Year Founded: 2000-10-31
Core Business: AtriCure, Inc. engages development, manufacture and sale of devices designed primarily for the surgical ablation of cardiac tissue, and systems for the exclusion of the left atrial appendage. Its products include radio Frequency (RF) ablation pacing and sensing, cryo, left atrial appendage management, soft tissue dissection, estech surgical instrumentation, and cart configuration. It operates through the following geographical segments: United States, Europe, Asia, Other International, and Total International. The company was founded by Michael D. Hooven on October 31, 2000 and is headquartered in West Chester, OH.